Veracyte, Inc.
VCYT- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001384101
In the last 90 days, Veracyte, Inc. insiders filed 0 open-market purchases and 6 sales; 370 institutions reported holding it in 13F filings for Q2 2026, worth $5.23B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q2 2026
Institutional positions in Veracyte, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 370
- +38 vs. Q1 2026
- Shares held
- 89.1M
- +1.01M (+1.1%) vs. Q1 2026
- Total value
- $5.23B
- +$2.39B (+84.4%) vs. Q1 2026
- New holders
- 79
- 128 more added
- Sold out
- 41
- 123 more reduced
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VCYT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 370 | $5.23B |
| Q1 2026 | 334 | $2.84B |
| Q4 2025 | 329 | $3.65B |
| Q3 2025 | 298 | $3.08B |
| Q2 2025 | 278 | $2.31B |
| Q1 2025 | 287 | $2.51B |
| Q4 2024 | 318 | $3.25B |
| Q3 2024 | 293 | $2.78B |
| Q2 2024 | 240 | $1.78B |
| Q1 2024 | 246 | $1.82B |
| Q4 2023 | 250 | $2.13B |
| Q3 2023 | 237 | $1.72B |
| Q2 2023 | 232 | $1.96B |
| Q1 2023 | 233 | $1.74B |
| Q4 2022 | 223 | $1.81B |
| Q3 2022 | 208 | $1.28B |
| Q2 2022 | 194 | $1.52B |
| Q1 2022 | 204 | $2.11B |
| Q4 2021 | 217 | $3.10B |
| Q3 2021 | 215 | $3.47B |
| Q2 2021 | 215 | $2.91B |
| Q1 2021 | 235 | $3.93B |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Veracyte, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −298−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −150−100.0% | Sold out |
| Root Financial Partners, LLC | 0 | $0 | 0.00% | −126−100.0% | Sold out |
| Scarborough Advisors, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Blue Bell Private Wealth Management, LLC | 0 | $0 | 0.00% | −85−100.0% | Sold out |
| Twin Peaks Wealth Advisors, LLC | 0 | $0 | 0.00% | −66−100.0% | Sold out |
| Wealth Preservation Advisors, LLC | 0 | $0 | 0.00% | −49−100.0% | Sold out |
| Picton Mahoney Asset Management | 0 | $0 | 0.00% | −37−100.0% | Sold out |
| Rachor Investment Advisory Services, LLC | 0 | $0 | 0.00% | −26−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| Vermillion Wealth Management, Inc. | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Janus Henderson Group PLC | – | – | – | – | Not filed |
| CWM, LLC | – | – | – | – | Not filed |